Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

50 results about "Multiple alleles" patented technology

Multiple alleles. Alleles are the pairs of genes occupying a specific spot called locus on a chromosome. Typically, there are only two alleles for a gene in a diploid organism. When there is a gene existing in more than two allelic forms this condition is referred to as multiple allelism.

Restrictive two-stage genome-wide association study (GWAS) method based on SNPLDB mark

InactiveCN104651517AShorten the attenuation distanceMultiple allelic variationMicrobiological testing/measurementProteomicsMulti siteRegression analysis
The invention discloses a restrictive two-stage genome-wide association study (GWAS) method based on an SNPLDB mark, and aims at solving the problems that a traditional method cannot be used for estimating multiple allele information, and is high in false positive rate and low in efficiency of detection on inbreeding crops. By combination of the SNPLDB mark constructed on the basis of a haplotype block, correction of deviation of an inbreeding population relation analysis model and a two-stage relation analysis strategy under a multi-site model, the GWAS method suitable for conventional breeding of inbreeding crops is built; the SNPLDB mark is applied to GWAS, so that a method is provided for multiple allele estimation; candidate sites are screened on the basis of a single-site model in the first stage, and are further screened on the basis of a progressive regression analysis method in the multi-site model in the second stage, so as to balance the problems of missing of heritability and over-high heritability estimation. Therefore, the interpretation ratio of a final genetic model is controlled at trait heritability. The positioning accuracy and efficiency are improved by a feature vector and an appropriate significant level of a similarity coefficient matrix estimated by the SNPLDB mark by GWAS.
Owner:NANJING AGRICULTURAL UNIVERSITY

Composite amplification system for detecting 129 molecular genetic markers of four types based on NGS technology

The invention belongs to the field of innovative research and application of a new forensic medicine technology, and particularly relates to a composite amplification system for detecting multiple molecular genetic markers based on a next-generation sequencing platform. The method comprises the following steps: screening 48 AISNPs for different intercontinental and domestic group forensic medicine progenitor inference and analysis on the basis of an HGDP-CPEH database; 18 multi-allele InDel sites with high polymorphism distribution in domestic populations are screened on the basis of a thousand-person genome plan; 27 micro-haplotypes with high application value in domestic populations are screened based on previous research reports; 34 Y-SNP sites and 2 Y-InDel sites are selected for male individual haplogroup distribution research; and based on a next-generation sequencing platform, synchronous amplification detection analysis of the multiple genetic markers is realized by adopting a multiple PCR method. The system can be used for simultaneously realizing forensic individual identification, genetic relationship identification, mixed sample resolution, forensic initial ancestor analysis and male individual haplogroup distribution research aiming at a field physical evidence inspection material, and can provide more comprehensive and valuable biological information for forensic application research.
Owner:朱波峰 +3

Methods of treating hearing disorders

The present disclosure provides methods for treating a hearing disorder associated with maladaptive neuroplasticity, reduction of inhibition, shift of excitation-to-inhibition balance, changes in central gain, and/or changes in neural sensitivity in a subject by inhibiting the function and/or production of tumor necrosis factor alpha (TNF-α) in the subject. The present disclosure provides methods of administering to the subject a TNF-α inhibitory agent in an amount effective to treat the subject for a hearing disorder associated with maladaptive neuroplasticity, reduction of inhibition, shift of excitation-to-inhibition balance, changes in central gain, and/or changes in neural sensitivity. TNF-α inhibitory agents of the subject disclosure include agents that inhibit the function TNF-α, inhibit the production of TNF-α, inhibit TNF-α signaling, inhibit TNF-α expression, or inhibit TNF-α signaling pathway genes in the subject. The present disclosure also provides methods for treating a hearing disorder associated with maladaptive neuroplasticity, reduction of inhibition, shift of excitation-to-inhibition balance, changes in central gain, and/or changes in neural sensitivity in a subject by disrupting one or more alleles of a TNF-α signaling pathway gene in a cell of the subject.
Owner:WAYNE STATE UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products